NINDS Neuroscience Funding Announcements

Basic and Clinical Research on Rett Syndrome and MECP2 (R01)

Funding Contact(s): Laura Mamounas, Ph.D.
Funding Categories: Neurogenetics

Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH), the International Rett Syndrome Association (IRSA) and the Rett Syndrome Research Foundation (RSRF) invite research grant applications aimed at understanding and/or treating Rett Syndrome (RTT). The recent demonstration that mutations in the MECP2 gene cause most cases of RTT has created new opportunities for both basic and clinical research. Included within the scope of this Program Announcement with set-aside funds (PAS) are developmental, neuroanatomical, molecular genetic, and pathophysiological research, therapy development projects and clinical studies. Studies of the role of MeCP2 in basic biological processes or in the etiology of other neurological or neurobehavioral disorders are also appropriate.

Grant Mechanism: R01
NIH Guide: PAS-05-024
Release Date: 2004-11-26
Expiration Date: 2007-01-03